Philip Toleikis - Sernova Corp CEO and President and Director

SEOVF Stock  USD 0.33  0.01  3.13%   

CEO

Dr. Philip M. Toleikis is President, Chief Executive Officer of Sernova Corporationration From 2006 until joining Sernova, Dr. Toleikis was consultant for a number of device, combination product and pharmaceutical companies. From 19962006 he held multiple roles at Angiotech Pharmaceuticals, Inc. including Vice President, Research and Development Pharmacology and Drug Screening where he built a product development team of over 50 scientists and was responsible for multiple corporate and academic collaborations since 2015.
Tenure 9 years
Phone519 858 5184
Webhttps://www.sernova.com
Toleikis is the author of multiple issued patents, over 110 patent applications, and multiple scientific publications involving metabolic, cardiovascular, oncology, and autoimmune disease. He obtained his Ph.D. in Medicine, Pharmacology and Therapeutics from the University of British Columbia, his M.Sc. at the University of Michigan and B.A. at the University of Vermont. Among a number of volunteer activities he is a speaker at JDRF events, and a community member of UHP school council in London, Ontario

Sernova Corp Management Efficiency

The company has return on total asset (ROA) of (0.3759) % which means that it has lost $0.3759 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.6454) %, meaning that it generated substantial loss on money invested by shareholders. Sernova Corp's management efficiency ratios could be used to measure how well Sernova Corp manages its routine affairs as well as how well it operates its assets and liabilities.
The company has accumulated 307.4 K in total debt with debt to equity ratio (D/E) of 0.01, which may suggest the company is not taking enough advantage from borrowing. Sernova Corp has a current ratio of 17.89, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist Sernova Corp until it has trouble settling it off, either with new capital or with free cash flow. So, Sernova Corp's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Sernova Corp sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Sernova to invest in growth at high rates of return. When we think about Sernova Corp's use of debt, we should always consider it together with cash and equity.

Similar Executives

Found 5 records

CEO Age

James HallLifecore Biomedical
61
Richard NanulaLucy Scientific Discovery
63
Hermann LuebbertBiofrontera
68
Isao TeshirogiShionogi Co
64
Frank LeePacira Pharmaceuticals
56
Sernova Corp. operates as a clinical-stage regenerative medicine therapeutics company in Canada. The company was incorporated in 1998 and is headquartered in London, Canada. Sernova Corp operates under Biotechnology classification in the United States and is traded on OTC Exchange. Sernova Corp [SEOVF] is traded as part of a regulated electronic over-the-counter service offered by the NASD.

Management Performance

Sernova Corp Leadership Team

Elected by the shareholders, the Sernova Corp's board of directors comprises two types of representatives: Sernova Corp inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Sernova. The board's role is to monitor Sernova Corp's management team and ensure that shareholders' interests are well served. Sernova Corp's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Sernova Corp's outside directors are responsible for providing unbiased perspectives on the board's policies.
Ralph Deiterding, CFO
Douglas Maret, Chief Officer
Bruce Weber, Director
Philip Toleikis, CEO and President and Director
James Parsons, Director
Ray Matthews, IR Contact Officer
Jeffrey Bacha, Independent Director
CA CA, Chief Officer
Scott Langille, CFO
Sean Hodgins, CFO
Frank Holler, Director
Christopher Barnes, VP Relations
Frank MBA, Ex Chairman
BA MSc, CEO Pres

Sernova Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right otc stock is not an easy task. Is Sernova Corp a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Sernova Corp in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Sernova Corp's short interest history, or implied volatility extrapolated from Sernova Corp options trading.

Currently Active Assets on Macroaxis

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sernova Corp. Also, note that the market value of any otc stock could be tightly coupled with the direction of predictive economic indicators such as signals in real.
You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.

Complementary Tools for Sernova OTC Stock analysis

When running Sernova Corp's price analysis, check to measure Sernova Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sernova Corp is operating at the current time. Most of Sernova Corp's value examination focuses on studying past and present price action to predict the probability of Sernova Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sernova Corp's price. Additionally, you may evaluate how the addition of Sernova Corp to your portfolios can decrease your overall portfolio volatility.
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Stocks Directory
Find actively traded stocks across global markets
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Money Managers
Screen money managers from public funds and ETFs managed around the world
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Please note, there is a significant difference between Sernova Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Sernova Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Sernova Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.